Nabi Biopharmaceuticals and Biota Holdings Limited Amend Terms of Business Combination; Mangrove Partners Agrees to Support the Amended Transaction
September 17, 2012 17:46 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Sept. 17, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it has agreed on revised terms with Biota Holdings Limited (ASX:BTA.AX) with respect to...
Biota in Advanced Discussions With Russell H. Plumb to Assume Role of President and CEO of Biota Pharmaceuticals, Inc.
September 06, 2012 16:53 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md. and MELBOURNE, Australia, Sept. 6, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nadsaq:NABI) today announced that Biota Holdings Limited (ASX:BTA.AX) has entered into advanced...
Nabi Sends Letter to Stockholders Responding to Mangrove's Statements and Calls on Stockholders to Vote Their White Proxy Card Today
August 23, 2012 06:50 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Aug. 23, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that it is sending a letter to its stockholders, a copy of which is included below. The letter...
Nabi Biopharmaceuticals Announces Second Quarter 2012 Financial Results
August 09, 2012 16:15 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Aug. 9, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its second quarter financial results for the three-month period ended June 30, 2012. The Company...
Nabi Biopharmaceuticals Announces Final Results of Its Self-Tender Offer
August 02, 2012 16:30 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Aug. 2, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) (the "Company") today announced the final results of its "modified Dutch auction" tender offer, which expired at...
Nabi Biopharmaceuticals Announces Second Quarter 2012 Financial Results Release Date
August 02, 2012 13:50 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Aug. 2, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its second quarter 2012 financial results on Thursday, August 9, after the...
Nabi Biopharmaceuticals Announces Preliminary Results of Its Self-Tender Offer
July 31, 2012 16:51 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., July 31, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) (the "Company") today announced the preliminary results of its "modified Dutch auction" tender offer, which...
Nabi Biopharmaceuticals Announces Waiver of Cash Reserve Tender Offer Condition
July 19, 2012 06:50 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., July 19, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) (the "Company") announced today, in connection with its previously announced tender offer (for up to $23 million...
Nabi Biopharmaceuticals Announces Commencement of Self-Tender Offer for Up To $23,000,000 of Its Common Stock
July 02, 2012 06:50 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., July 2, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) (the "Company") today announced that it is commencing a "modified Dutch auction" tender offer for up to...
Nabi Biopharmaceuticals Announces First Quarter 2012 Financial Results
May 10, 2012 16:15 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., May 10, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its first quarter financial results for the three-month period ended March 31, 2011. The Company...